HAP Partners With Peerfit to Provide Flexible Fitness Options for Active Seniors
Health Alliance Plan (HAP), a Michigan-based nonprofit health plan, is partnering with UF startup Peerfit, a digital health technology company, to bring Peerfit Move to its Medicare Advantage members.
Glint Pharmaceuticals Announces Formation of Clinical Advisory Board
UF startup Glint Pharmaceuticals, an ophthalmic pharmaceutical company that delivers medicated contact lenses to treat eye diseases, announces the formation of a clinical advisory board composed of notable and experienced clinicians in ophthalmology and optometry.
FLIR Systems Acquires UF Startup Altavian, Inc.
FLIR Systems, Inc., a company specializing in the design and production of thermal imaging cameras, components and imaging sensors, announced that it has acquired UF startup Altavian, Inc., a privately-held manufacturer of small unmanned aerial systems (sUAS) for defense and public safety customers.
AGTC Goes Mobile to Avoid Clinical Trial Chaos
When leaders of UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC realized how disruptive COVID-19 might become, they developed a plan—several of them, in fact—to minimize clinical chaos.
Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.
UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has announced the change of its corporate name to Panbela Therapeutics, Inc. effective December 2, 2020.
Pets, Perseverance, and Manufacturing Facility Bring Biotech Success
Patricia Lawman, co-founder and CEO of the biotech firm Morphogenesis, a UF startup and UF Innovate | Sid Martin Biotech graduate company, has always been amazed at how our bodies can defeat illnesses and usually do it better than drugs.
AbFero to Receive € 2M Eurostars Funding for Parkinson’s Disease Therapy
AbFero Ltd., a subsidiary of UF startup AbFero Pharmaceuticals, Inc., a privately-held clinical-stage pharmaceutical company dedicated to treating diseases of iron overload, announced the funding of approximately € 2M from EUREKA Eurostars for the development of iron-chelating compounds including their lead agent, SP-420, as a disease-modifying therapy for Parkinson’s disease.
UF Startup Helping Veterinarians Take Animal Vital Signs Brings Its Product to the Zoo
Vik Ramprakash, founder of UF startup Structured Monitoring Products (SMP), is making the process of taking vital signs easier and safer. The company’s VetGuardian monitor remotely gathers vital signs, including temperature, pulse and respiration of sick, injured or post-operative animals.
UF Researcher Finds a Way to Mitigate Acute Respiratory Distress Syndrome (ARDS), a Complication of Coronavirus Infection
Why would a doctor specializing in gastrointestinal disorders be interested in therapy for COVID-19, a primarily pulmonary disease? The answer lies in a seemingly convoluted link between the gastrointestinal tract and the lungs: water.
TearClear Announces Successful Completion of Pre-IND Meeting With the FDA for a Preservative Free Multi-Dose Delivery of Latanoprost for the Treatment of Glaucoma
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, announced successful completion of pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development plan for the preservative free multi-dose delivery of a proprietary Latanoprost formulation, including the clinical study design for the registration study.